B L Kemp
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
Papers in
-
- Epigenetics and DNA Methylation 4
- Glutathione Transferases and Polymorphisms 2
- Wnt/β-catenin signaling in development and cancer 2
-
- Cancer Genomics and Diagnostics 4
- Breast Cancer Treatment Studies 2
- Co-authors
- Fadlo R. Khuri (6 shared papers)J. Jack Lee (5 shared papers)Scott M. Lippman (3 shared papers)Jonathan M. Kurie (4 shared papers)Waun Ki Hong (4 shared papers)W K Hong (1 shared paper)Lei Feng (1 shared paper)Reuben Lotan (1 shared paper)
- Journals
- British Journal of Cancer (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Journal of Clinical Oncology (1 paper)Lung Cancer (1 paper)American Journal of Roentgenology (1 paper)
- Partner nations
- United States
In The Last Decade
B L Kemp
19 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 96
- Cancer Research 324
- Oncology 505
- Pharmacology 231
- Genetics 325
- Molecular Biology 690
Countries citing papers authored by B L Kemp
This map shows the geographic impact of B L Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B L Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B L Kemp more than expected).
Fields of papers citing papers by B L Kemp
This network shows the impact of papers produced by B L Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B L Kemp. The network helps show where B L Kemp may publish in the future.
Co-authors
The 25 scholars most cited alongside B L Kemp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 343 | |
| 2 | Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. | 2001 | 340 |
| 3 | Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. | 2000 | 96 |
| 4 | Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. | 1998 | 91 |
| 5 | Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. | 1999 | 91 |
| 6 | 1996 | 87 | |
| 7 | Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. | 1999 | 80 |
| 8 | Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. | 1998 | 64 |
| 9 | Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer. | 2000 | 42 |
| 10 | C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers. | 2000 | 36 |
| 11 | 1999 | 28 | |
| 12 | TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer. | 2001 | 24 |
| 13 | 2001 | 17 | |
| 14 | 1999 | 11 | |
| 15 | Calcofluor white stain for the detection of Pneumocystis carinii in transbronchial lung biopsy specimens: a study of 68 cases. | 1996 | 10 |
| 16 | Acute myelofibrosis--a leukemia of pluripotent stem cell. A report of three cases and review of the literature. | 1991 | 10 |
| 17 | Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content. | 1996 | 5 |
| 18 | 1998 | 2 | |
| 19 | 1999 | 1 | |
| 20 | 1997 | 1 |
About B L Kemp
B L Kemp is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Genetics and Oncology, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer Genomics and Diagnostics (4 papers), Breast Cancer Treatment Studies (2 papers), Glutathione Transferases and Polymorphisms (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Virus-based gene therapy research (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (324 citations), Oncology (505 citations), Pharmacology (231 citations), Genetics (325 citations) and Molecular Biology (690 citations). B L Kemp has collaborated with scholars based in United States. Frequent co-authors include Fadlo R. Khuri, J. Jack Lee, Scott M. Lippman, Jonathan M. Kurie, Waun Ki Hong, W K Hong, Lei Feng, Reuben Lotan, Hong Wu and Li Mao. Their work appears in journals such as British Journal of Cancer, JNCI Journal of the National Cancer Institute, Journal of Clinical Oncology, Lung Cancer and American Journal of Roentgenology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.